Johnny Kao, M.D. is originally from New York City and graduated with honors from Dartmouth College. He completed medical school training at Mount Sinai School of Medicine and radiation oncology residency training at University of Chicago.
He served as Assistant Professor at Mount Sinai School of Medicine for 5 years where he started an active stereotactic body radiation therapy program. At Mount Sinai, he developed and tested several new treatment combinations of radiation therapy and biologically targeted anticancer treatments. For example, Dr. Kao was principal investigator of the first clinical trial to combine stereotactic body radiation therapy with
Sutent for patients with metastases to the lung, liver, bone or lymph nodes. Although metastatic cancers have historically been considered incurable, approximately 30% of treated patients continue to be in a complete remission more than 2 years after treatment. Dr. Kao also developed new treatment regimens for patients with advanced or recurrent head and neck cancers, including patients that recurred after previous
radiation. Dr. Kao joined Florida Radiation Oncology Group in 2010 and is committed to bringing cutting edge treatment options to patients in Hillsborough County. In 2010, Florida Cancer Physicians Network was developed and Tampa Bay Cancer Center is a proud member.
Dr. Kao is a member of numerous professional organizations, including American Society for Therapeutic Radiology and Oncology, American Society of Clinical Oncologists and the American Association of Cancer Research. Dr. Kao was a past president of the New York Roentgen Society Section of Radiation Oncology and is board certified in radiation oncology by the American Board of Radiology. He has authored more than 30 peer-reviewed papers and 10 book chapters in the areas of prostate, head and neck and breast cancers, stereotactic body radiation for metastatic tumors and cancer biology. He has been invited to speak at numerous local, national and international cancer meetings. In addition to receiving nearly $2,000,000
in research grants, Dr. Kao was awarded the Patients’ Choice award based on high patient satisfaction.